DFX Intelligence
Private Equity Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Transactions / P•••••• o• E••••••• R••••••••
C•••• Sells P•••••• o• E••••••• R•••••••• to O••••••• Capital for up to $135.7 Million
Platform acquisitionannouncedannounced Mar 25, 2019Fact
What happened
- Platform
- not an add-on on record
- Control
- Control
- Share acquired
- unknown
- Industry
- unknown
- Target location
- unknown
- Seller kind
- Unknown
- Rollover
- unknown
Values, only where disclosed
- Enterprise value
- Not disclosed
- Purchase price
- Not disclosed
- Equity value
- Not disclosed
- Target revenue
- Not disclosed
- Target EBITDA
- Not disclosed
- Multiple
- Not disclosed
Parties and roles
4 named
Buy side
- ““E••••••• is an attractive asset commercialized by a world-class marketer and we are pleased to partner with C•••• as it advances its clinical pipeline” said A••••• R•••••••••, Managing Partner of O••••••• Capital.”
- “O••••••• Capital, a private investment firm with over $1.2 billion in capital commitments since inception, is focused exclusively on investing in the global healthcare industry and specializes in flexible investment structures customized to meet the specific capital requirements and strategic object”
Sell side
- “C•••• Sells P•••••• o• E••••••• R•••••••• to O••••••• Capital for up to $135.7 Million”
Side not stated
- “C•••• Sells P•••••• o• E••••••• R•••••••• to O••••••• Capital for up to $135.7 Million”
Evidence
“C•••• Sells P•••••• o• E••••••• R•••••••• to O••••••• Capital for up to $135.7 Million”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026